These results follow similar findings from the companys ATTAIN-1 trial released earlier this month, which tested the drug on people who were overweight or obese without type 2 diabetes (in general, people without diabetes tend to lose more weight from GLP-1 therapy than those with diabetes)
International Journal of Obesity, 39 (12), 17031709
Suddenly they seem, (with some notable provisos see below), like a real possibility
Control Blood Sugar: They help your body produce the right amount of insulin after meals, preventing spikes and dips in blood sugar levels
While the classical incretin concept is based on the assumption that incretin hormones such as GIP and GLP-1 reach their main endocrine target cells via the bloodstream, there is some evidence that GIP (and possibly GLP-1) can be produced in relatively small amounts in endocrine alpha-cells of the pancreas [3]
Yaribeygi, H., Jamialahmadi, T., Moallem, S.A., Sahebkar, A